Big Pharma clicks soared, but new cell therapies made you buzz: What drove biopharma interest in 2023?

[Adobe Stock]

The big Big Pharma names you couldn’t ignore

Despite biopharma’s 2023 layoffs and challenges, innovation won your clicks last year with over 130,000 of them on our Pharma 50 report alone. But while giants dominated, your clicks showed disruptive tech wasn’t far behind. The next-most popular article was a roundup of 100 trailblazing cell and gene therapy companies with more than 80,000 views. Other hits included companies putting AI in drug discovery and development, and the ever-popular biotech startup watch – proof that solutions, not just statistics, attract attention. Rounding out the top five was a roundup of biotech job cuts and openings.

2023 biopharma innovation in the spotlight on Linkedin

But over on LinkedIn, innovation was also a driver of interest. Topics on women’s health, such as Organon doubling down on women’s health, novel approaches to mental illness at…

Read more
  • 0